Science Explorer Back to mapMap
Discussion
Company · Urbino · Italy

Erydel (Italy)

Research works
6
▼ 60% vs 2018-21
Citations
202
33.7 per fractional work
Top-10% rate
3.5%
all institutions 10.0%
Open access
65%
world 40%
International
36%
world 18%

Not ranked overall: Erydel (Italy) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Erydel (Italy) work in?

In all years, 75% of research at Erydel (Italy) is in Health Sciences, 23% in Life Sciences. Its largest fields are Medicine (67%), Biochemistry, Genetics and Molecular Biology (20%), Health Professions (8%). It does 1.7× the world's share of Health Sciences.

Health Sciences: 4 fractional works · 75.3% of its workMedicine: 4 fractional works · 66.9% of its workPhysiology: 1 fractional works · 24.9% of its workPulmonary and Respiratory Medicine: 1 fractional works · 11.4% of its workHematology: 1 fractional works · 9.5% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 6.5% of its workOncology: 0 fractional works · 4.0% of its workSurgery: 0 fractional works · 3.7% of its workNeurology: 0 fractional works · 1.8% of its workOrthopedics and Sports Medicine: 0 fractional works · 1.8% of its workRheumatology: 0 fractional works · 1.8% of its workPharmacology: 0 fractional works · 1.3% of its workHealth Professions: 0 fractional works · 8.4% of its workOccupational Therapy: 0 fractional works · 8.4% of its workLife Sciences: 1 fractional works · 22.9% of its workBiochemistry, Genetics and Molecular Biology: 1 fractional works · 20.1% of its workMolecular Biology: 1 fractional works · 13.9% of its workClinical Biochemistry: 0 fractional works · 2.8% of its workBiochemistry: 0 fractional works · 1.2% of its workCell Biology: 0 fractional works · 1.2% of its workGenetics: 0 fractional works · 1.2% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 1.3% of its workToxicology: 0 fractional works · 1.3% of its workNeuroscience: 0 fractional works · 0.8% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.8% of its workImmunology and Microbiology: 0 fractional works · 0.7% of its workImmunology: 0 fractional works · 0.7% of its workPhysical Sciences: 0 fractional works · 1.8% of its workMaterials Science: 0 fractional works · 1.8% of its workBiomaterials: 0 fractional works · 1.8% of its workALL ITS WORKErydel (Italy)6fractional works, all years
Life Sciences23%Physical Sciences2%Health Sciences75%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 7 fields, with their numbers
    1. Medicine466.9%
    2. Health Professions08.4%
    1. Biochemistry, Genetics and Molecular Biology120.1%
    2. Pharmacology, Toxicology and Pharmaceutics01.3%
    3. Neuroscience00.8%
    4. Immunology and Microbiology00.7%
    1. Materials Science01.8%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

What are the most cited papers from Erydel (Italy)?

The most cited paper from Erydel (Italy) is "Targeting the scaffolding role of LSD1 (KDM1A) poises acute myeloid leukemia cells for retinoic acid–induced differentiation" (Roberto Ravasio, Elena Ceccacci, Luciano Nicosia et al., 2020), with 104 citations. Next come "Positive effect of erythrocyte-delivered dexamethasone in ataxia-telangiectasia" (80) and "Engineering erythrocytes for the modulation of drugs' and contrasting agents' pharmacokinetics and biodistribution" (62).

Most cited papers
#PaperReleasedCitations
1 Targeting the scaffolding role of LSD1 (KDM1A) poises acute myeloid leukemia cells for retinoic acid–induced differentiation Roberto Ravasio, Elena Ceccacci, Luciano Nicosia et al. · Science Advances Open access 8 Apr 2020 104
2 Positive effect of erythrocyte-delivered dexamethasone in ataxia-telangiectasia Vincenzo Leuzzi, Roberto Micheli, Daniela D’Agnano et al. · Neurology Neuroimmunology & Neuroinflammation Open access 9 Apr 2015 80
3 Engineering erythrocytes for the modulation of drugs' and contrasting agents' pharmacokinetics and biodistribution Luigia Rossi, Francesca Pierigè, A. Antonelli et al. · Advanced Drug Delivery Reviews ReviewOpen access 15 May 2016 62
4 Approaches to erythrocyte-mediated drug delivery Mauro Magnani, Luigia Rossi · Expert Opinion on Drug Delivery 19 Feb 2014 62
5 Red Blood Cell Membrane Processing for Biomedical Applications Luigia Rossi, Alessandra Fraternale, Marzia Bianchi et al. · Frontiers in Physiology Open access 20 Aug 2019 56
All 20 most cited papers, with filters and sorting

Which research topics does Erydel (Italy) publish most on?

By volume in 2022-now: Glycosylation and Glycoproteins Research, Erythrocyte Function and Pathophysiology, Blood properties and coagulation and Pancreatic function and diabetes.

  1. 1 Glycosylation and Glycoproteins Research Molecular Biology 0 works
  2. 2 Erythrocyte Function and Pathophysiology Physiology 0 works
  3. 3 Blood properties and coagulation Pulmonary and Respiratory Medicine 0 works
  4. 4 Pancreatic function and diabetes Surgery 0 works
  5. 5 Folate and B Vitamins Research Rheumatology 0 works
  6. 6 Biochemical and Molecular Research Molecular Biology 0 works
  7. 7 Metabolism and Genetic Disorders Clinical Biochemistry 0 works
  8. 8 Adipose Tissue and Metabolism Physiology 0 works
  9. 9 Genetic Neurodegenerative Diseases Cellular and Molecular Neuroscience 0 works
  10. 10 Radiation Therapy and Dosimetry Pulmonary and Respiratory Medicine 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available65.4%not open34.6%

World: 40% of research is openly available.

with international co-authors35.7%domestic only64.3%

World: 18% is written across borders.

How has Erydel (Italy)'s research output changed?

Output in 2022-2025 was 60% lower than in 2018-2021.

20152020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Erydel (Italy) as a percentage of every work published that year, 0.0000093% in 2023.

0.000010%0.000020%0.000030%Erydel (Italy)0.0000033% in 20242020

Fractional works of Erydel (Italy) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Urbino

All research institutions in Urbino

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Erydel (Italy). Posts are plain text and can be reported.